Aptamers and antisense oligonucleotides for diagnosis and treatment of hematological diseases
Aptamers or chemical antibodies are single-stranded DNA or RNA oligonucleotides that
bind proteins and small molecules with high affinity and specificity by recognizing tertiary or …
bind proteins and small molecules with high affinity and specificity by recognizing tertiary or …
Oligonucleotide aptamer-mediated precision therapy of hematological malignancies
S Yang, H Li, L Xu, Z Deng, W Han, Y Liu… - … Therapy-Nucleic Acids, 2018 - cell.com
Precision medicine has recently emerged as a promising strategy for cancer therapy
because it not only specifically targets cancer cells but it also does not have adverse effects …
because it not only specifically targets cancer cells but it also does not have adverse effects …
Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy
Z Poon, N Dighe, SS Venkatesan, AMS Cheung, X Fan… - Leukemia, 2019 - nature.com
The study of myelodysplastic syndromes (MDS) in murine models has now indicated the
possible involvement of the bone marrow microenvironment in the generation of dysplastic …
possible involvement of the bone marrow microenvironment in the generation of dysplastic …
Membrane-wrapped nanoparticles for enhanced chemotherapy of acute myeloid leukemia
This work reports the development of a biomimetic membrane-wrapped nanoparticle
(MWNP) platform for targeted chemotherapy of acute myeloid leukemia (AML). Doxorubicin …
(MWNP) platform for targeted chemotherapy of acute myeloid leukemia (AML). Doxorubicin …
[HTML][HTML] What is the value of counting mast cells in gastrointestinal mucosal biopsies?
NC Panarelli, JL Hornick, RK Yantiss - Modern Pathology, 2023 - Elsevier
Neoplastic and nonneoplastic mast cell disorders can cause diarrhea, nausea, and
abdominal pain that result from heightened release of mast cell mediators. Systemic …
abdominal pain that result from heightened release of mast cell mediators. Systemic …
Class III receptor tyrosine kinases in acute leukemia–biological functions and modern laboratory analysis
R Berenstein - Biomarker insights, 2015 - journals.sagepub.com
Acute myeloid leukemia (AML) is a complex disease caused by deregulation of multiple
signaling pathways. Mutations in class III receptor tyrosine kinases (RTKs) have been …
signaling pathways. Mutations in class III receptor tyrosine kinases (RTKs) have been …
Association of ABCB1 and ABCG2 single nucleotide polymorphisms with clinical findings and response to chemotherapy treatments in Kurdish patients with breast …
The possible interaction between gene polymorphisms and risk of cancer progression is
very interesting. Polymorphisms in multi-drug resistance genes have an important role in …
very interesting. Polymorphisms in multi-drug resistance genes have an important role in …
[HTML][HTML] MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway
JC Lee, S Liu, Y Wang, Y Liang, DM Jablons - Oncotarget, 2022 - ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is the most lethal form of AML due to disease relapse. Cyclin
dependent kinase 8 (CDK8) is a serine/threonine kinase that belongs to the family of Cyclin …
dependent kinase 8 (CDK8) is a serine/threonine kinase that belongs to the family of Cyclin …
Metodología y aplicaciones de la citometría de flujo para el inmunofenotipaje de las leucemias agudas
V Marsán Suárez, LO del Valle Pérez… - Revista Cubana de …, 2015 - scielo.sld.cu
La citometría de flujo (CMF) es una técnica de avanzada, altamente sensible y
automatizada, que se emplea para el inmunofenotipaje de las células normales y …
automatizada, que se emplea para el inmunofenotipaje de las células normales y …
Characterization of Human B Cell Hematological Malignancies Using Protein-Based Approaches
C Jiménez, A Garrote-de-Barros… - International Journal of …, 2024 - mdpi.com
The maturation of B cells is a complex, multi-step process. During B cell differentiation,
errors can occur, leading to the emergence of aberrant versions of B cells that, finally …
errors can occur, leading to the emergence of aberrant versions of B cells that, finally …